Smith Thornton Advisors LLC Amgen Inc Transaction History
Smith Thornton Advisors LLC
- $174 Billion
- Q2 2025
A detailed history of Smith Thornton Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Smith Thornton Advisors LLC holds 1,272 shares of AMGN stock, worth $374,756. This represents 0.2% of its overall portfolio holdings.
Number of Shares
1,272
Previous 1,247
2.0%
Holding current value
$374,756
Previous $389 Million
8.63%
% of portfolio
0.2%
Previous 0.24%
Shares
4 transactions
Others Institutions Holding AMGN
# of Institutions
3,275Shares Held
442MCall Options Held
6.15MPut Options Held
7.25M-
Vanguard Group Inc Valley Forge, PA53.7MShares$15.8 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$8.65 Billion0.32% of portfolio
-
Capital International Investors Los Angeles, CA18.9MShares$5.57 Billion0.95% of portfolio
-
Capital World Investors Los Angeles, CA16.9MShares$4.97 Billion0.71% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $158B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...